Zomedica Pharmaceuticals Appoints Anthony Blair as Chief Operating Officer
MT Newswires · 06/15 16:40
Zomedica to acquire innovative veterinary imaging company, Revo Squared assets
Zomedica (NYSE:ZOM) signed a definitive agreement to acquire substantially all of the assets of Revo Squared. Revo's innovative MicroView digital cytology platform will provide veterinarians with best-in-class image quality while providing
Seekingalpha · 06/15 10:44
Zomedica Pharmaceuticals Agrees to Acquire Veterinary Imaging Company for Undisclosed Terms
MT Newswires · 06/15 06:34
Zomedica makes strategic investment to acquire pet monitoring platform
The veterinary health company Zomedica (NYSE:ZOM) announced Thursday the purchase of a $1.0 million convertible note of Ohio-based animal care company Structured Monitoring Products, Inc. giving it an option to
Seekingalpha · 05/19 11:13
Zomedica Enters Into Strategic Investment And Potential Collaboration For VetGuardian Monitoring Product Line
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it has purchased a $1.0
Benzinga · 05/19 10:33
Zomedica Makes Strategic Investment, Gets Option to Rep VetGuardian Monitoring Platform
MT Newswires · 05/19 06:51
Why Zomedica Shares Are Falling Today
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session. Zomedica reported a first-quarter EPS loss of four tenths of one cent on revenue of $3.751 mil...
Benzinga · 05/11 19:51
Zomedica reports Q1 results
Zomedica press release (NYSE:ZOM): Q1 net loss of $3.9M. Revenue of $3.8M. Total revenues of $3.8 million were up 38% over the combined revenues of Zomedica and PulseVet as a
Seekingalpha · 05/10 20:50
Notable earnings before Wednesday's open
Seekingalpha · 05/10 14:33
Zomedica Announces Launch Of eACTH Assay For Truforma(R) Platform
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced the commercial launch of its
Benzinga · 04/04 10:53
Zomedica's 2021 Net Loss Flat as Company Reports Revenue
MT Newswires · 03/02 03:56
Why Zomedica Shares Are Rising
Zomedica Corp (NASDAQ: ZOM) shares are trading higher by 14% at $0.40 during Monday’s session after the company reported fourth-quarter sales of $4.10 million.
Benzinga · 02/28 14:45
Zomedica Announces Participation in the Q1 Virtual Investor Summit
Ann Arbor, Michigan--(Newsfile Corp. - February 28, 2022) - Zomedica (AMEX: ZOM) today announced that Larry Heaton, CEO will be attending the Q1 Virtual Investor Summit. During the presentation, Zomedica’s Chief Executive Officer, Larry Heaton, will highli...
Newsfile · 02/28 12:30
Zomedica gains as new acquisition drives Q4 topline growth
The shares of Zomedica (NYSE:ZOM) have surged ~23% in the post-market Friday on above-average volume after the micro-cap animal health company reported more than $4M revenue for the final quarter and full-year
Seekingalpha · 02/25 21:54
Zomedica GAAP EPS of -$0.05 misses by $0.04, revenue of $4.1M misses by $0.3M
Zomedica press release (NYSE:ZOM): FY GAAP EPS of -$0.05 misses by $0.04. Revenue of $4.1M misses by $0.3M. Shares +16.7%. As of December 31, 2020, we had an accumulated deficit
Seekingalpha · 02/25 21:42
Zomedica Reports Big Jump in Q4 Revenue; Shares Rising in Late Friday Trade
MT Newswires · 02/25 16:51
Sargent Bickham Lagudis LLC Buys iShares Core S&P 500 ETF, Vanguard FTSE Emerging Markets ...
Investment company Sargent Bickham Lagudis LLC (Current Portfolio) buys iShares Core S&P 500 ETF, Vanguard FTSE Emerging Markets ETF, Berkshire Hathaway Inc, iShares MSCI ACWI Index Fund, iShares Core S&P Small-Cap ETF, sells BTC iShares Core MSCI EAFE ETF... · 01/18 22:38
Zomedica CEO Provides Update To Shareholders
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today issued the following letter from Larry
Benzinga · 01/10 11:36
There’s a Reason to Consider Buying Zomedica, and It’s a Real Shocker
Investor Place · 01/07 14:58
Zomedica posts widening Q3 net loss as SG&A expenses more than doubles
Zomedica (NYSE:ZOM) has lost ~5.5% in the post-market after the company reported Q3 2021 financials that indicated rising net loss amid a surge in selling, general and administrative expenses (SG&A) for the quarter.
Seekingalpha · 11/12/2021 22:39
Webull provides a variety of real-time ZOM stock news. You can receive the latest news about Zomedica Corp through multiple platforms. This information may help you make smarter investment decisions.
About ZOM
Zomedica Corp. is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. The Company is developing point-of-care diagnostic platform, which is based on miniaturized laser-based Raman spectroscopy technology and is designed to detect pathogens in companion animals. It offers TRUFORMA is a diagnostic biosensor platform and the first five assays for the detection of thyroid disorders in dogs and cats and adrenal disorders in dogs. The TRUFORMA platform uses bulk acoustic wave (BAW) technology to provide a non-optical and fluorescence free detection system for use at the point-of-care. The TRUFORMA also offers complete control over the testing process from start to finish, with sensitive and specific immunoassays that allow veterinarians to make clinical decisions.